不用本金就能赚钱的方法

来宝网Logo

热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

现在位置不用本金就能赚钱的方法>技术资料不用本金就能赚钱的方法>行业动态>行业动态>PGXL和SureGene联合推出STA2R试剂盒

PGXL和SureGene联合推出STA2R试剂盒

互联网2012年9月3日 13:27 点击:3711

美国SureGene,
PGXL和SureGene联合推出STA2R试剂盒

SureGene和PGXL Laboratories联合推出了STA2R试剂盒(SureGene Test for Antipsychotic and Antidepressant Response (STA2R),抗精神病药物及抗抑郁药物响应检测试剂盒),这是一种药理基因学检测(pharmacogenetic test),包含抗精神病药物治疗有效性的基因标志物。

STA2R,SHIYIZUJIYINJIANCE,NENGGOUWEILINCHUANGYISHENGTIGONGXINDEXINXI,YONGYUBANGZHUXUANZEGEXINGHUADEKANGJINGSHENBINGYAOWUJIKANGYIYUYAOWU。GAICESHIHAIYOUZHUYULINCHUANGYISHENGQUEDINGCHUDUILIPEITONGZHILIAOYOUJINJIDEHUANZHE。STA2RJIANGSULT4A1-1JIYINBIAOQIANYULINGWAI4GEJIYINCESHIJIEHEZAIYIQI。

SureGeneZONGCAIBill MasseyCHENG,STA2RJIANGGAIBIANJINGSHENFENLIEZHENGJISHUANGXIANGZHANGAIDEZHILIAO。

STA2RJIANCEXUYAOZAILINCHUANGYISHENGBANGONGSHIGUAQUKOUQIANGNIANMO,RANHOUZHIYUYUFUFEIDEYUNSHURONGQIZHONG,SONGDAPGXLSHIYANSHI,BINGZAIJITIANZHINEI,LINCHUANGYISHENGJIUNENGSHOUDAOYIFENANQUANBAOGAO。

SureGene发现SULT4A1基因标签并申请了专利,PGXL实验值则自主开发了STA2R试剂盒。 
 

SureGene, PGXL Partner on PGx Test for Antipsychotic Drugs

 

NEW YORK (GenomeWeb News) – Psychiatric molecular diagnostic firm SureGene today announced it is partnering with PGXL Laboratories to launch a five-gene test for determining which patients may be best candidates for the most widely used antipsychotics and antidepressants.

不用本金就能赚钱的方法The two University of Louisville spinouts will co-promote the test, called the SureGene Test for Antipsychotic and Antidepressant Response, or STA2R. SureGene is working with healthcare providers to market the test, while PGXL will do so through its own distribution network.

STA2R comprises five genes including SULT4A1-1. In clinical studies, Caucasian schizophrenic patients with the genetic signature who were treated with olanzapine showed reduced psychotic symptoms, SureGene said, adding that SULT4A1-1 positive patients treated with the drug also had a "significantly" lower risk of being hospitalized.

不用本金就能赚钱的方法In addition, the test was able to help identify those patients for whom risperidone, the current standard treatment in psychotic symptoms, is contraindicated, as well as patients who may not respond to certain antidepressants.

SureGene discovered and patented SULT4A1-1, and PGXL independently developed STA2R. The test consists of a cheek swab that is performed in a provider's office and then sent to PGXL. The CLIA-certified laboratory headquartered in Louisville, Ky., will perform an analysis and send a report to the clinician.

The deal is the first between SureGene, also based in Louisville, and PGXL. Financial and other terms of the deal were not disclosed.

"STA2R represents a revolutionary change to the treatment of schizophrenia and bipolar disorder," Bill Massey, president and CEO of SureGene, said in a statement. "For the first time, physicians will have a test that can help them prioritize the treatment choices for their patients."

However, SureGene isn't the only firm offering a pharmacogenomic test for such drug response. AssureRx Health, a Cincinnati-based personalized medicine company, offers the GeneSightRx pharmacogenetic testing program for psychotropic drugs. Its test includes a panel of 32 medications, 20 of which are antidepressants and 12 are antipsychotics.

 

 

(来源: 互联网 )


全年征稿 / 资讯合作

联系邮箱:kefu@strauss-usa.com

BANQUANYUMIANZESHENGMING

  • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://strauss-usa.com,违反者本网将追究相关法律责任。
  • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
  • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。


湖南快乐十分 湖南快乐十分 福建快3走势图0 福建快3走势图 河南快3走势图 河南快3走势图 广东11选5开奖结果 福建11选5走势图